Gujarat Inject (Kerala) quarterly results and financials

Gujarat Inject (Kerala) (BSE 524238)₹10.84+0.18%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (standalone), Gujarat Inject (Kerala) reported sales of ₹12.42 Cr, up 415.4% from Jun 2025, and net profit of ₹1.26 Cr, up 1,475.0% year on year. For the year to Mar 2026, sales were ₹36.22 Cr and net profit ₹1.82 Cr.

Sales (Jun 2026): ₹12.42 Cr
Net profit (Jun 2026): ₹1.26 Cr
Sales (FY Mar 2026): ₹36.22 Cr
Net profit (FY Mar 2026): ₹1.82 Cr
EPS (Jun 2026): ₹0.10
Borrowings (Mar 2026): ₹0 Cr

Company filings, standalone accounts; latest reported quarter Jun 2026

Gujarat Inject (Kerala) quarterly results

₹ crore unless stated; each column is a quarter.

Gujarat Inject (Kerala) Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	0.00	0.21	5.41	3.04	8.59	3.14	4.23	2.41	1.57	1.62	30.61	12.42
Expenses	0.00	0.24	5.36	2.87	8.06	2.86	4.14	2.31	1.54	1.71	28.37	10.73
Operating Profit	0.00	−0.04	0.06	0.18	0.55	0.29	0.10	0.11	0.04	−0.10	2.28	1.70
OPM %	—	−13.8%	0.9%	5.5%	6.2%	8.8%	2.1%	4.1%	1.9%	−5.6%	7.3%	13.5%
Other Income	0.01	0.05	0.00	0.00	0.16	0.00	0.00	0.00	0.05	0.13	0.00	0.00
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	0.03	0.02	0.04	0.18	0.72	0.29	0.11	0.11	0.10	0.06	2.26	1.70
Tax %	0.0%	0.0%	20.0%	23.5%	14.1%	25.0%	30.0%	20.0%	22.2%	20.0%	27.7%	26.0%
Net Profit	0.02	0.00	0.05	0.13	0.62	0.22	0.08	0.08	0.08	0.05	1.65	1.26
EPS (Rs)	0.00	0.00	0.00	0.02	0.05	0.02	0.00	0.00	0.00	0.00	0.12	0.10

Gujarat Inject (Kerala) profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

Gujarat Inject (Kerala) Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	0.01	1.56	0.00	0.00	0.00	0.00	0.01	0.16	5.78	18.99	36.22	46.22
Expenses	0.01	1.55	0.06	0.02	0.00	0.12	0.06	0.53	5.73	17.95	33.95	42.35
Operating Profit	0.00	0.02	−0.08	−0.04	−0.02	−0.13	−0.06	−0.38	0.06	1.08	2.31	3.92
OPM %	0.0%	0.6%	—	—	—	−1,200.1%	−250.1%	−217.7%	0.9%	5.6%	6.3%	8.5%
Other Income	2.29	0.00	0.04	0.01	0.00	0.00	0.04	0.42	0.05	0.17	0.19	0.18
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Profit before tax	2.31	0.02	−0.03	−0.02	0.00	−0.12	0.00	0.07	0.10	1.26	2.49	4.12
Tax %	0.0%	0.0%	0.0%	0.0%	—	0.0%	—	16.7%	18.1%	19.2%	27.6%	—
Exceptional items	2.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
Net Profit	2.31	0.02	−0.03	−0.02	0.00	−0.12	0.00	0.05	0.09	1.03	1.82	3.04
EPS (Rs)	0.48	0.00	0.00	0.00	0.00	−0.03	0.00	0.02	0.02	0.08	0.13	0.22
Dividend payout %	0.0%	0.0%	0.0%	0.0%	—	0.0%	—	0.0%	0.0%	0.0%	0.0%	—

Gujarat Inject (Kerala) balance sheet

₹ crore, at each year end.

Gujarat Inject (Kerala) Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	4.89	4.89	4.89	4.89	4.89	4.89	4.89	4.89	4.89	11.31	14.64	14.64
Reserves	−7.93	−5.62	−5.62	−5.65	−5.64	−5.64	−5.75	−5.74	−5.70	−2.74	−4.60	−2.80
Borrowings	2.85	0.55	0.56	0.58	0.58	0.58	0.68	0.72	0.60	0.00	0.00	0.00
Other Liabilities	0.37	0.35	0.19	0.21	0.19	0.19	0.21	0.21	0.52	0.14	1.94	24.93
Total Liabilities	0.18	0.17	0.02	0.03	0.02	0.02	0.03	0.08	0.31	8.71	11.98	36.77
Fixed Assets	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	20.82
CWIP	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Assets	0.18	0.17	0.02	0.03	0.02	0.02	0.03	0.08	0.31	8.71	11.98	15.95
Trade receivables	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2.99	7.19	6.34
Cash & equivalents	0.03	0.01	0.03	0.00	0.00	0.02	0.00	0.02	0.07	2.93	0.04	0.69
Total Assets	0.18	0.17	0.02	0.03	0.02	0.02	0.03	0.08	0.31	8.71	11.98	36.77

Gujarat Inject (Kerala) cash flow

₹ crore, for each year.

Gujarat Inject (Kerala) Cash flow
	Mar 2018	Mar 2021	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	0.00	−0.10	0.04	−6.02	−1.54	21.20
Cash from investing activity	0.00	0.00	0.00	0.00	0.19	−20.58
Cash from financing activity	0.00	0.09	0.00	8.86	−1.52	0.00
Net cash flow	−0.02	0.00	0.06	2.87	−2.90	0.66
Capex	0.00	0.00	0.00	0.00	0.00	20.79
Free cash flow	0.00	−0.10	0.04	−6.01	−1.54	0.45
CFO / OP %	14.0%	92.0%	−16.0%	−12,020.0%	−122.0%	953.0%

Gujarat Inject (Kerala) ratios

Working-capital days and returns, by year.

Gujarat Inject (Kerala) Ratios
	Mar 2016	Mar 2017	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	0	0	0	0	0	189	139	65
Inventory days	—	0	0	0	0	0	0	0
Cash conversion cycle	0	0	0	0	0	188	138	64
Working capital days	−8,395	−107	−17,520	−9,490	−1,546	355	153	−140
ROCE %	—	—	—	—	—	2.7%	13.6%	22.9%

Gujarat Inject (Kerala): frequently asked questions

What are the latest quarterly results of Gujarat Inject (Kerala)?

For the Jun 2026 quarter, Gujarat Inject (Kerala) reported sales of ₹12.42 Cr, up 415.4% year on year and net profit of ₹1.26 Cr, up 1,475.0% year on year. The operating margin was 13.5%.

What is the annual revenue of Gujarat Inject (Kerala)?

Gujarat Inject (Kerala)'s sales for the year to Mar 2026 were ₹36.22 Cr; over the last twelve months they were ₹46.22 Cr.

What is the net profit of Gujarat Inject (Kerala)?

Net profit for the year to Mar 2026 was ₹1.82 Cr, and ₹3.04 Cr over the last twelve months. Earnings per share over the same trailing period were ₹0.22.

How much debt does Gujarat Inject (Kerala) have?

Gujarat Inject (Kerala) reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.69 Cr.

What is the free cash flow of Gujarat Inject (Kerala)?

Cash from operations was ₹21.20 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹0.45 Cr.

Loading…